Occlusive arterial disease, including coronary heart disease (CHD) and peripheral arterial
disease (PAD), is the main cause of death, with an annual mortality incidence predicted to …

Recent advancements in the bioinks and three-dimensional (3D) bioprinting methods used
to fabricate vascular constructs are summarized herein. Critical biomechanical properties …

To date, a wide range of materials, from synthetic to natural or a mixture of these, has been
explored, modified, and examined as small-diameter tissue-engineered vascular grafts (SD …

Pathologies related to the cardiovascular system are the leading causes of death worldwide.
One of the main treatments is conventional surgery with autologous transplants. Although …

Abstract 3D bioprinting is an emerging additive manufacturing technique to fabricate
constructs for human disease modeling. However, current cell‐laden bioinks lack sufficient …

Polymeric biomaterials have revolutionized biomedical technology and related fields as
biomaterials for health-care applications. Recent trend in polymeric medical technology has …

There is a high demand for small diameter vascular grafts having mechanical and biological
properties similar to that of living tissues. Tissue-engineered vascular grafts using current …

Several patient groups undergoing small-diameter (< 6 mm) vessel bypass surgery have
limited autologous vessels for use as grafts. Tissue-engineered vascular grafts (TEVG) have …

Cardiovascular-related medical conditions remain a significant cause of death worldwide
despite the advent of tissue engineering research more than half a century ago. Although …

Cardiovascular disease is a primary cause of mortality worldwide, and patients often require
bypass surgery that utilizes autologous vessels as conduits. However, the limited availability …